Development of a Carvedilol Oral Liquid Formulation for Paediatric Use

Carvedilol (CARV) is an ‘off-label’ β-blocker drug to treat cardiovascular diseases in children. Since CARV is nearly insoluble in water, only CARV solid forms are commercialized. Usually, CARV tablets are manipulated to prepare an extemporaneous liquid formulation for children in hospitals. We stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiclana-Rodríguez, Blanca, Garcia-Montoya, Encarnacion, Rouaz-El Hajoui, Khadija, Romero-Obon, Miquel, Nardi-Ricart, Anna, Suñé-Pou, Marc, Suñé-Negre, Josep M., Pérez-Lozano, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537783/
https://www.ncbi.nlm.nih.gov/pubmed/37765252
http://dx.doi.org/10.3390/pharmaceutics15092283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537783/
https://www.ncbi.nlm.nih.gov/pubmed/37765252
http://dx.doi.org/10.3390/pharmaceutics15092283

Ejemplares similares